Literature DB >> 8431691

Focal nodular hyperplasia of the liver: radiologic findings.

K Shamsi1, A De Schepper, H Degryse, F Deckers.   

Abstract

A retrospective analysis of the results of ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI) of 24 cases (28 lesions) of proven focal nodular hyperplasia (FNH) is presented. While US exhibited nonspecific features, CT frequently showed characteristic features: hypodensity on precontrast scans (69%), transient immediate enhancement after bolus injection (96%), and homogeneity (85%). A scar was noted in 31% of the cases. The typical MR triad of isointensity on T1- and/or T2-weighted (T2-WI), homogeneity, and a scar which shows hyperintensity on T2-WI was seen in only 12% of our cases. The most common finding was homogeneity (94%). In two cases the scar was hypointense on T2-WI. To our knowledge, this finding has not been described before. We conclude that the features of FNH, although fairly constant, are at times indistinguishable from those of other hepatic tumors, such as hepatic adenoma (HA), fibrolamellar hepatocellular carcinoma (FLHCC), small hepatocellular carcinoma, and a hyperplastic nodule. Therefore, a multimodality approach is essential for the correct diagnosis in order to prevent unnecessary surgery.

Entities:  

Mesh:

Year:  1993        PMID: 8431691     DOI: 10.1007/bf00201698

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  24 in total

1.  Focal nodular hyperplasia of the liver on delayed enhanced CT.

Authors:  R Kier; A T Rosenfield
Journal:  AJR Am J Roentgenol       Date:  1989-10       Impact factor: 3.959

2.  Angiographic and echographic findings in avascular focal nodular hyperplasia of the liver.

Authors:  N O Whitley; J J Cunningham
Journal:  AJR Am J Roentgenol       Date:  1978-04       Impact factor: 3.959

3.  MR imaging of hepatic focal nodular hyperplasia: characterization and distinction from primary malignant hepatic tumors.

Authors:  G R Mattison; G M Glazer; L E Quint; I R Francis; R L Bree; W D Ensminger
Journal:  AJR Am J Roentgenol       Date:  1987-04       Impact factor: 3.959

4.  Primary liver tumors: diagnosis by MR imaging.

Authors:  E Rummeny; R Weissleder; D D Stark; S Saini; C C Compton; W Bennett; P F Hahn; J Wittenberg; R A Malt; J T Ferrucci
Journal:  AJR Am J Roentgenol       Date:  1989-01       Impact factor: 3.959

5.  Association of focal nodular hyperplasia and hepatic hemangioma.

Authors:  D Mathieu; E S Zafrani; M C Anglade; D Dhumeaux
Journal:  Gastroenterology       Date:  1989-07       Impact factor: 22.682

6.  Portal vein involvement in hepatocellular carcinoma: dynamic CT features.

Authors:  D Mathieu; P Grenier; D Lardé; N Vasile
Journal:  Radiology       Date:  1984-07       Impact factor: 11.105

7.  Clinical application of superparamagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumors.

Authors:  P F Hahn; D D Stark; R Weissleder; G Elizondo; S Saini; J T Ferrucci
Journal:  Radiology       Date:  1990-02       Impact factor: 11.105

8.  MR imaging of hepatic focal nodular hyperplasia.

Authors:  R J Butch; D D Stark; R A Malt
Journal:  J Comput Assist Tomogr       Date:  1986 Sep-Oct       Impact factor: 1.826

9.  The sonographic "scar sign" in focal nodular hyperplasia of the liver.

Authors:  J C Scatarige; E K Fishman; R C Sanders
Journal:  J Ultrasound Med       Date:  1982-09       Impact factor: 2.153

10.  Hepatic tumors: magnetic resonance and CT appearance.

Authors:  A A Moss; H I Goldberg; D B Stark; P L Davis; A R Margulis; L Kaufman; L E Crooks
Journal:  Radiology       Date:  1984-01       Impact factor: 11.105

View more
  22 in total

Review 1.  Focal nodular hyperplasia--a review of myths and truths.

Authors:  Christopher B Nahm; Kevin Ng; Philip Lockie; Jaswinder S Samra; Thomas J Hugh
Journal:  J Gastrointest Surg       Date:  2011-09-30       Impact factor: 3.452

Review 2.  Benign liver lesions: grey-scale and contrast-enhanced ultrasound appearances.

Authors:  A E Obaro; S M Ryan
Journal:  Ultrasound       Date:  2015-03-12

3.  Usefulness of novel imaging modalities in diagnosis of focal nodular hyperplasia of the liver.

Authors:  Y Nishigaki; E Tomita; Y Matsuno; K Goto; T Ohnishi; Y Tanaka; H Iwai; H Asano; I Yasuda; K Nagura; T Wakahara; T Yamada
Journal:  J Gastroenterol       Date:  1997-10       Impact factor: 7.527

4.  Focal nodular hyperplasia with retraction of liver capsule: a case report.

Authors:  Kyung Ran Ko; Dong Ho Lee; Ji Seon Park; Bum Ha Yi; Joo Won Lim; Young Tae Ko; Youn Wha Kim
Journal:  Korean J Radiol       Date:  2003 Jan-Mar       Impact factor: 3.500

5.  Focal nodular hyperplasia of the liver: an emerging complication of hematopoietic SCT in children.

Authors:  M Pillon; N S Carucci; C Mainardi; E Carraro; M Zuliani; L Chemello; E Calore; M Tumino; S Varotto; T Toffolutti; R Destro; M V Gazzola; R Alaggio; G Basso; C Messina
Journal:  Bone Marrow Transplant       Date:  2015-01-12       Impact factor: 5.483

6.  Focal nodular hyperplasia of the liver in men: is presentation the same in men and women?

Authors:  A Luciani; H Kobeiter; P Maison; D Cherqui; E-S Zafrani; D Dhumeaux; D Mathieu
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

Review 7.  Benign liver tumors in pediatric patients - Review with emphasis on imaging features.

Authors:  Liliana Chiorean; Xin-Wu Cui; Andrea Tannapfel; Doris Franke; Martin Stenzel; Wojciech Kosiak; Dagmar Schreiber-Dietrich; Jörg Jüngert; Jian-Min Chang; Christoph F Dietrich
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

Review 8.  Use of second generation contrast-enhanced ultrasound in the assessment of focal liver lesions.

Authors:  Stanislas-H Morin; Adrian-Kp Lim; Jeremy-Fl Cobbold; Simon D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

9.  Diagnosis and management of hepatic focal nodular hyperplasia.

Authors:  A Venturi; F Piscaglia; G Vidili; S Flori; R Righini; R Golfieri; L Bolondi
Journal:  J Ultrasound       Date:  2007-08-01

Review 10.  Distinguishing benign from malignant liver tumours.

Authors:  Jay P Heiken
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.